Redmile Group, LLC Alx Oncology Holdings Inc Transaction History

Redmile Group, LLC

  • $908 Million
  • Q3 2025

A detailed history of Redmile Group, LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Redmile Group, LLC holds 3,332,983 shares of ALXO stock, worth $4.27 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
3,332,983
Previous 3,391,455 1.72%
Holding current value
$4.27 Million
Previous $1.42 Million 328.3%
% of portfolio
0.67%
Previous 0.17%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$0.44 - $1.87 $25,727 - $109,342
-58,472 Reduced 1.72%
3,332,983 $6.1 Million
Q2 2025

Aug 14, 2025
SELL
$0.41 - $0.61 $102,245 - $152,121
-249,379 Reduced 6.85%
3,391,455 $1.42 Million
Q1 2025

May 15, 2025
SELL
$0.62 - $1.86 $30,241 - $90,725
-48,777 Reduced 1.32%
3,640,834 $2.26 Million
Q4 2024

Feb 14, 2025
SELL
$1.21 - $1.87 $177,827 - $274,824
-146,965 Reduced 3.83%
3,689,611 $6.16 Million
Q3 2024

Nov 14, 2024
SELL
$1.81 - $8.13 $361,773 - $1.62 Million
-199,875 Reduced 4.95%
3,836,576 $6.98 Million
Q2 2024

Aug 14, 2024
SELL
$5.84 - $17.56 $1.69 Million - $5.09 Million
-290,058 Reduced 6.7%
4,036,451 $24.3 Million
Q1 2024

May 15, 2024
BUY
$10.95 - $16.79 $7.31 Million - $11.2 Million
667,245 Added 18.23%
4,326,509 $48.2 Million
Q4 2023

Feb 14, 2024
BUY
$4.81 - $15.38 $11.4 Million - $36.5 Million
2,375,975 Added 185.15%
3,659,264 $54.5 Million
Q2 2023

Aug 14, 2023
BUY
$4.37 - $9.56 $3.04 Million - $6.66 Million
696,312 Added 118.63%
1,283,289 $9.64 Million
Q1 2023

May 15, 2023
SELL
$4.52 - $11.71 $92,628 - $239,973
-20,493 Reduced 3.37%
586,977 $2.65 Million
Q4 2022

Feb 14, 2023
SELL
$9.51 - $12.95 $1.38 Million - $1.87 Million
-144,627 Reduced 19.23%
607,470 $6.85 Million
Q3 2022

Nov 14, 2022
SELL
$8.23 - $15.14 $120,981 - $222,558
-14,700 Reduced 1.92%
752,097 $7.2 Million
Q2 2022

Aug 15, 2022
SELL
$5.89 - $19.46 $32,984 - $108,976
-5,600 Reduced 0.73%
766,797 $6.2 Million
Q1 2022

May 16, 2022
SELL
$13.65 - $22.06 $132,405 - $213,982
-9,700 Reduced 1.24%
772,397 $13.1 Million
Q4 2021

Feb 14, 2022
SELL
$21.49 - $74.4 $1.77 Million - $6.13 Million
-82,338 Reduced 9.53%
782,097 $16.8 Million
Q3 2021

Nov 15, 2021
SELL
$52.51 - $80.91 $2.6 Million - $4.01 Million
-49,600 Reduced 5.43%
864,435 $63.8 Million
Q2 2021

Aug 16, 2021
SELL
$52.2 - $75.23 $3.37 Million - $4.86 Million
-64,565 Reduced 6.6%
914,035 $50 Million
Q1 2021

May 17, 2021
BUY
$62.84 - $87.68 $1.14 Million - $1.6 Million
18,200 Added 1.9%
978,600 $72.2 Million
Q4 2020

Feb 16, 2021
BUY
$34.11 - $112.26 $18.9 Million - $62.1 Million
553,000 Added 135.74%
960,400 $82.8 Million
Q3 2020

Nov 16, 2020
BUY
$29.36 - $47.1 $12 Million - $19.2 Million
407,400 New
407,400 $15.4 Million

Others Institutions Holding ALXO

# of Institutions
69
Shares Held
30.3M
Call Options Held
173K
Put Options Held
0
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $52.2M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email